ARCHIVES

Rumors Preceded Broder’s Move

This article is from The Cancer Letter archive.

Vol. 20 No. 49 | December 22, 1994

Download PDF Visit The Full Archive

Related Articles

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

October 16, 2009

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

January 26, 1996